Digest Network Come funziona
Network
/
Società
Cu
Non verificato

CuraSen Therapeutics, Inc.

Di cosa scriviamo

FarmaceuticaMedicina - VarieSaluteTerza etàVetrine/Shopping

4 comunicati stampa

Guarda tutti i comunicati
10/11/2025
Eventi
Salute
Vetrine/Shopping
Terza età
Medicina - Varie
Farmaceutica
Biotecnologia
CuraSen Therapeutics Presents Positive Phase 1 Safety, Pharmacokinetics and Pharmacodynamics Data with CuraAX (CST-3056) at the 2025 American Autonomic Society (AAS) International Symposium
Fonte
CuraSen Therapeutics, Inc.
Emittente
Business Wire
1.00
0
23/10/2025
Industria
Salute
Medicina - Varie
Scienza
Farmaceutica
CuraSen Therapeutics Doses First Patient with CuraAX (CST-3056) in Phase 2a Neurogenic Orthostatic Hypotension (nOH) Study
Fonte
CuraSen Therapeutics, Inc.
Emittente
Business Wire
1.00
0
20/02/2025
Psichiatria
Salute
Vetrine/Shopping
Terza età
Medicina - Varie
Farmaceutica
Biotecnologia
CuraSen Therapeutics Announces First Subject Treated with CuraAX (CST-3056) in a Phase 1 Clinical Trial
Fonte
CuraSen Therapeutics, Inc.
Emittente
Business Wire
1.00
0
15/10/2024
CuraSen Therapeutics Appoints Kathleen Sereda Glaub Chief Executive Officer
Fonte
CuraSen Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0